End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.33 USD | +6.21% | +3.26% | -8.26% |
May. 21 | Sipai Health Technology Co., Ltd. Announces Board Changes | CI |
Mar. 19 | Sipai Health Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Strengths
- With regards to fundamentals, the enterprise value to sales ratio is at 0.87 for the current period. Therefore, the company is undervalued.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Sector: Drug Retailers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-8.26% | 617M | - | ||
-37.88% | 13.99B | B- | ||
-33.12% | 10.67B | B | ||
-22.64% | 6.75B | B | ||
+12.54% | 6.29B | C | ||
-11.17% | 5.88B | C+ | ||
+75.00% | 4.96B | C | ||
-2.92% | 4.54B | D- | ||
-9.20% | 3.74B | B | ||
-19.40% | 3.16B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- 314 Stock
- Ratings Sipai Health Technology Co., Ltd.